• Mashup Score: 8

    A growing trend of off-label, low-dose antipsychotic prescribing to treat disorders such as anxiety and insomnia has been tied to an increased risk of cardiometabolic death.

    Tweet Tweets with this article
    • A growing trend of off-label, low-dose #antipsychotic prescribing to treat disorders such as #anxiety and #insomnia has been tied to an increased risk of cardiometabolic death. https://t.co/cbHuqM3AQs https://t.co/gZCb8tZaYI

  • Mashup Score: 2

    A growing trend of off-label, low-dose antipsychotic prescribing to treat disorders such as anxiety and insomnia has been tied to an increased risk of cardiometabolic death.

    Tweet Tweets with this article
    • A growing trend of off-label, low-dose #antipsychotic prescribing to treat disorders such as #anxiety and #insomnia has been tied to an increased risk of cardiometabolic death. https://t.co/aHTtDJaRXa #TwitteRx https://t.co/ceK6OtpQDA

  • Mashup Score: 2

    A popular antipsychotic calms patients with multiple sclerosis (MS) who develop psychiatric distress after taking corticosteroids, a new case review suggests.

    Tweet Tweets with this article
    • The popular #antipsychotic quetiapine seems to calm patients with #multiplesclerosis who develop psychiatric distress after taking corticosteroids, a new case review says. https://t.co/aqWU8Kk3rg